Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:mrsn | https://www.glassdoor.com?employer_id=1687179 | 1687179 | Apr 28th, 2024 12:00AM | Open | Mersana Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2001 | 4.10 | -100% | 69% | 80% | 4.40 | 4.50 | 4.10 | 4.40 | 3.90 | 3.90 | 1.00 | 2.00 | 4.00 | 14.00 | 21.00 | 19.00 | 0.00 | 4.762% | 9.524% | 19.048% | 66.667% | 3.00 | 9.00 | 36.00 | 1.00 | 1.00 | Open | Martin Huber | Apr 28th, 2024 04:19PM | Apr 28th, 2024 04:19PM | Mersana Therapeutics | ||||||||||||||||
nasdaq:mrsn | https://www.glassdoor.com?employer_id=1687179 | 1687179 | Apr 26th, 2024 12:00AM | Open | Mersana Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2001 | 4.10 | -100% | 69% | 80% | 4.40 | 4.50 | 4.10 | 4.40 | 3.90 | 3.90 | 1.00 | 2.00 | 4.00 | 14.00 | 21.00 | 19.00 | 0.00 | 4.762% | 9.524% | 19.048% | 66.667% | 3.00 | 36.00 | 1.00 | 1.00 | Open | Martin Huber | Apr 26th, 2024 08:05AM | Apr 26th, 2024 08:05AM | Mersana Therapeutics | |||||||||||||||||
nasdaq:mrsn | https://www.glassdoor.com?employer_id=1687179 | 1687179 | Apr 25th, 2024 12:00AM | Open | Mersana Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2001 | 4.10 | -100% | 69% | 80% | 4.40 | 4.50 | 4.10 | 4.40 | 3.90 | 3.90 | 1.00 | 2.00 | 4.00 | 14.00 | 21.00 | 19.00 | 0.00 | 4.762% | 9.524% | 19.048% | 66.667% | 3.00 | 9.00 | 36.00 | 1.00 | 1.00 | Open | Martin Huber | Apr 25th, 2024 06:27PM | Apr 25th, 2024 06:27PM | Mersana Therapeutics | ||||||||||||||||
nasdaq:mrsn | https://www.glassdoor.com?employer_id=1687179 | 1687179 | Apr 24th, 2024 12:00AM | Open | Mersana Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2001 | 4.10 | -100% | 69% | 80% | 4.40 | 4.50 | 4.10 | 4.40 | 3.90 | 3.90 | 1.00 | 2.00 | 4.00 | 14.00 | 21.00 | 19.00 | 0.00 | 4.762% | 9.524% | 19.048% | 66.667% | 3.00 | 14.00 | 36.00 | 1.00 | 1.00 | Open | Martin Huber | Apr 24th, 2024 10:50AM | Apr 24th, 2024 10:50AM | Mersana Therapeutics | ||||||||||||||||
nasdaq:mrsn | https://www.glassdoor.com?employer_id=1687179 | 1687179 | Apr 23rd, 2024 12:00AM | Open | Mersana Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2001 | 4.10 | -100% | 69% | 80% | 4.40 | 4.50 | 4.10 | 4.40 | 3.90 | 3.90 | 1.00 | 2.00 | 4.00 | 14.00 | 21.00 | 19.00 | 0.00 | 4.762% | 9.524% | 19.048% | 66.667% | 3.00 | 14.00 | 36.00 | 1.00 | 1.00 | Open | Martin Huber | Apr 23rd, 2024 04:24PM | Apr 23rd, 2024 04:24PM | Mersana Therapeutics | ||||||||||||||||
nasdaq:mrsn | https://www.glassdoor.com?employer_id=1687179 | 1687179 | Apr 21st, 2024 12:00AM | Open | Mersana Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2001 | 4.10 | -100% | 69% | 80% | 4.40 | 4.50 | 4.10 | 4.40 | 3.90 | 3.90 | 1.00 | 2.00 | 4.00 | 14.00 | 21.00 | 19.00 | 0.00 | 4.762% | 9.524% | 19.048% | 66.667% | 3.00 | 14.00 | 36.00 | 1.00 | 1.00 | Open | Martin Huber | Apr 21st, 2024 04:25PM | Apr 21st, 2024 04:25PM | Mersana Therapeutics | ||||||||||||||||
nasdaq:mrsn | https://www.glassdoor.com?employer_id=1687179 | 1687179 | Apr 20th, 2024 12:00AM | Open | Mersana Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2001 | 4.10 | -100% | 69% | 80% | 4.40 | 4.50 | 4.10 | 4.40 | 3.90 | 3.90 | 1.00 | 2.00 | 4.00 | 14.00 | 21.00 | 19.00 | 0.00 | 4.762% | 9.524% | 19.048% | 66.667% | 3.00 | 36.00 | 1.00 | 1.00 | Open | Martin Huber | Apr 20th, 2024 04:41PM | Apr 20th, 2024 04:41PM | Mersana Therapeutics | |||||||||||||||||
nasdaq:mrsn | https://www.glassdoor.com?employer_id=1687179 | 1687179 | Apr 19th, 2024 12:00AM | Open | Mersana Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2001 | 4.10 | -100% | 69% | 80% | 4.40 | 4.50 | 4.10 | 4.40 | 3.90 | 3.90 | 1.00 | 2.00 | 4.00 | 14.00 | 21.00 | 19.00 | 0.00 | 4.762% | 9.524% | 19.048% | 66.667% | 3.00 | 14.00 | 36.00 | 1.00 | 1.00 | Open | Martin Huber | Apr 19th, 2024 07:38AM | Apr 19th, 2024 07:38AM | Mersana Therapeutics | ||||||||||||||||
nasdaq:mrsn | https://www.glassdoor.com?employer_id=1687179 | 1687179 | Apr 18th, 2024 12:00AM | Open | Mersana Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2001 | 4.10 | -100% | 69% | 80% | 4.40 | 4.50 | 4.10 | 4.40 | 3.90 | 3.90 | 1.00 | 2.00 | 4.00 | 14.00 | 21.00 | 19.00 | 0.00 | 4.762% | 9.524% | 19.048% | 66.667% | 3.00 | 14.00 | 36.00 | 1.00 | 1.00 | Open | Martin Huber | Apr 18th, 2024 06:00PM | Apr 18th, 2024 06:00PM | Mersana Therapeutics | ||||||||||||||||
nasdaq:mrsn | https://www.glassdoor.com?employer_id=1687179 | 1687179 | Apr 17th, 2024 12:00AM | Open | Mersana Therapeutics | Open | Company - Public | Biotech & Pharmaceuticals | Cambridge, MA | 2001 | 4.10 | -100% | 69% | 80% | 4.40 | 4.50 | 4.10 | 4.40 | 3.90 | 3.90 | 1.00 | 2.00 | 4.00 | 14.00 | 21.00 | 19.00 | 0.00 | 4.762% | 9.524% | 19.048% | 66.667% | 3.00 | 14.00 | 36.00 | 1.00 | 1.00 | Open | Martin Huber | Apr 17th, 2024 02:28PM | Apr 17th, 2024 02:28PM | Mersana Therapeutics |